Sheraton Times Square, New York City
01 Sep 2021

2022 Venous Symposium in New York City

The 2022 Venous Symposium will be held from April 21–23, 2022 at the Sheraton New York Times Square Hotel. The Venous Symposium is the premier international conference on issues and treatment related to vein pathology. The symposium delivers practical education and updates on the current knowledge and management of venous

0
Loews Portofino Bay Hotel
01 Sep 2021

OEIS 8th Annual National Scientific Meeting

OEIS, The Outpatient Endovascular and Interventional Society, is hosting the 2021 OEIC Annual National Scientific Meeting from September 24–25, 2021, in Orlando. OEIS aims to enhance the safety, quality and patient satisfaction of outpatient endovascular and interventional procedures, develop standards of practice for the operation of outpatient endovascular and interventional

0
VIVA Conference presentation
01 Sep 2021

VIVA Conference 2021 in Las Vegas

For nearly two decades, VIVA has led the conversation in endovascular education. This year, VIVA will return to Wynn Las Vegas in October with new data, debates, and opportunities to connect with leaders in PVD care. Offering multidisciplinary perspectives on groundbreaking data presentations, challenging live case demonstrations, and sessions showcasing

0
01 Sep 2021

AVLS 35th Annual Congress 2021

The AVLS 2021 Annual Congress will be gathering at the Gaylord Rockies Resort & Convention Center in Denver, Col., from October 7 to 10. The 2021 sessions will focus on recent research in the field of venous and lymphatic disease, specifically around data from the AVLS PRO 2.0 Venous Registry.

0
14 Jun 2018

VEIN SPECIALISTS PODCAST WITH VTN’S OWN GARY PITTMAN

Gary Pittman from Vein Therapy News joins Vein Specialists today to discuss his background and experience with the vein industry. Vein Therapy News is teaming with the latest news on products, services, and breakthroughs in the vein treatment industry. We discuss technology and how it is changing the face of

0
02 Nov 2017

FDA approves DVT prevention device

California-based ManaMed has launched the U.S. Food and Drug Administration (FDA) approved deep vein thrombosis (DVT) prevention device PlasmaFlow in the United States. The portable, tubeless and digital PlasmaFlow, which comes with multiple pressure functions, helps to prevent the onset of DVT in patients by revitalizing blood flow in the

0
Reva scaffolding
02 Nov 2017

Reva scaffolding study yields good results

As some companies have worked to improve drug-eluting stents by making them bioresorbable, some voices in the coronary intervention space have expressed concern over the rates of late stent thrombosis and repeat percutaneous coronary intervention seen with the devices. In a study published in a recent issue of JACC: Cardiovascular

0
02 Nov 2017

Medtronic Concerto 3D Detachable Coil unveiled for vein embolization

Medtronic has unveiled its new Concerto 3D Detachable Coil System that is intended to be used for embolizations in the peripheral arteries and veins. The device was unveiled at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting in Copenhagen, Denmark in September. The device, which is now available to physicians

0
02 Nov 2017

Boston Scientific to distribute Veniti VICI Venous Stent

Veniti Inc., a research company in the advancement of treatment for deep venous disease, has announced that Boston Scientific will distribute its VICI Venous Stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries involved were not disclosed. Physicians treat the obstructive component

0
02 Nov 2017

Access Vascular HydroPICC cath raises $4M

Medical device developer Access Vascular has raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk. The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the risk of thrombosis. Financing will support the submission of an

0